Trial · NCT00803179
Growth Hormone Therapy for Wasting in Cystic Fibrosis
NCT00803179, Phase 1, Terminated, University of Massachusetts, Worcester; results first posted 2013-01-15
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Growth Hormone Therapy for Wasting in Cystic Fibrosis. Trials, record NCT00803179. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT00803179
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Growth Hormone Therapy for Wasting in Cystic Fibrosis
- NCT number
- NCT00803179
- Status
- Terminated
- Phases
- Phase 1
- Enrollment
- 5 participants, actual
- Lead sponsor
- University of Massachusetts, Worcester
- Conditions
- Cystic Fibrosis
- Interventions
- Nutropin AQ
- First posted
- 2008-12-05
- Last updated
- 2025-12-02
- Results first posted
- 2013-01-15
Source ClinicalTrials.gov
Registered outcomes2
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Measure Change in Weight in Adults With Cystic Fibrosis (CF) Related Wasting Following Growth Hormone (GH) Therapy | 14 months | |
| Secondary | Evaluate Overall Quality of Life (QOL) in Adults With CF Related Wasting Treated With GH Therapy | 14 months |
Source ClinicalTrials.gov
Outcomes2
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Measure Change in Weight in Adults With Cystic Fibrosis (CF) Related Wasting Following Growth Hormone (GH) Therapy | 14 months | The study was stopped prematurely due to lack of enrollment and dropout. There was not sufficient number of individuals completing the study to perform an analysis. | ||
| SECONDARY | Evaluate Overall Quality of Life (QOL) in Adults With CF Related Wasting Treated With GH Therapy | 14 months |
Source ClinicalTrials.gov
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow3
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Growth Hormone Therapy | 5 | |
| Overall Study | COMPLETED | Growth Hormone Therapy | 2 | |
| Overall Study | NOT COMPLETED | Growth Hormone Therapy | 3 |
Source ClinicalTrials.gov
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals3
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Growth Hormone Therapy | ||
| Total, other adverse events | Growth Hormone Therapy | 0 | 5 |
| Total, serious adverse events | Growth Hormone Therapy | 0 | 5 |
Source ClinicalTrials.gov
Papers1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as |
|---|---|
| 34424546 | DERIVED |
Source PubMed
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT00803179
GET https://conductscience.org/api/trials/v1/NCT00803179/registered